These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87. Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy. Wu J; Di D; Zhao C; Liu Y; Chen H; Gong Y; Zhao X; Chen H Curr Cancer Drug Targets; 2018; 18(6):558-566. PubMed ID: 29189160 [TBL] [Abstract][Full Text] [Related]
88. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing. Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397 [TBL] [Abstract][Full Text] [Related]
89. Targeting the GLI family of transcription factors for the development of anti-cancer drugs. Dusek CO; Hadden MK Expert Opin Drug Discov; 2021 Mar; 16(3):289-302. PubMed ID: 33006903 [TBL] [Abstract][Full Text] [Related]
90. Targeting GLI Transcription Factors in Cancer. Didiasova M; Schaefer L; Wygrecka M Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137 [TBL] [Abstract][Full Text] [Related]
91. Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer. Xie H; Paradise BD; Ma WW; Fernandez-Zapico ME Cells; 2019 Apr; 8(5):. PubMed ID: 31035664 [TBL] [Abstract][Full Text] [Related]